OptimizeRx Corp
OPRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$149.18M
Close$
$6.49
17.5% downside
Current Fair Value
17.5% downsideOvervalued by 17.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $149.18 Million |
|---|---|
| Enterprise Value | $145.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.28 |
| Beta | 1.05 |
| Outstanding Shares | 18,785,596 |
Return
| Return on Equity | 3.51% |
|---|---|
| Return on Assets | 2.80% |
| Return on Invested Capital | 0.72% |
Valuation & Multiples
| P/E Ratio | 32.64 |
|---|---|
| PEG | -22.37 |
| Price to Sales | 1.57 |
| Price to Book Ratio | 1.31 |
| Enterprise Value to Revenue | 1.47 |
| Enterprise Value to EBIT | 131 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$20.20 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.19
Average shareholder expectationRevenue Estimate
$21.62 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1410▲ 67.97% |
|---|---|
| Total Calls | 61,700▼ 41.07% |
| Total Puts | 70,400▲ 45.76% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 59.75%▼ 13.25% |
|---|---|
| Total Invested | $64.20M▼ 25.17% |
| Investors Holding | 117▼ 15.00% |
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...